Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies

文献类型: 外文期刊

第一作者: Li, Kai

作者: Li, Kai;Liu, Yongzhen;Zhang, Yanping;Gao, Li;Liu, Changjun;Cui, Hongyu;Qi, Xiaole;Gao, Yulong;Zhong, Li;Wang, Xiaomei

作者机构:

关键词: Marek's disease;Infectious bursal disease;Protective efficacy;Chicken;Maternal antibodies

期刊名称:VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY ( 影响因子:2.046; 五年影响因子:2.217 )

ISSN:

年卷期:

页码:

收录情况: SCI

摘要: Infectious bursal disease (IBD) causes significant clinical and economic losses to the poultry industry worldwide. Current vaccine programs using live attenuated and inactivated vaccines have numerous drawbacks. As an alternative solution to control IBD, a Marek's disease virus (MDV) vector vaccine (rMDV-VP2) expressing the VP2 gene of infectious bursal disease virus (IBDV) has been developed. In this study, the protective efficacy of rMDV-VP2 was evaluated in a dose-related experiment which showed that a single dose of 1000 PFU was sufficient to fully protect chickens against IBDV infection. Chickens inoculated with lower doses of rMDV-VP2 (250 or 500 PFU) conferred 80 and 90% protection against IBDV. Next, rMDV-VP2 vaccine provided 90% protection against IBDV in commercial layer chickens with maternal antibodies, which was higher than the protective efficacy using the B87 live vaccine of IBDV. Additionally, rMDV-VP2 conferred effective protection against very virulent MDV challenge in chickens (95% for chickens vaccinated with 250 or 500 PFU and 100% for chickens vaccinated with 1000 or 2000 PFU). These results demonstrated that rMDV-VP2 may be a novel bivalent vaccine against IBD and Marek's disease in chickens. (C) 2017 Elsevier B.V. All rights reserved.

分类号: Q96

  • 相关文献

[1]Chicken gga-miR-103-3p Targets CCNE1 and TFDP2 and Inhibits MDCC-MSB1 Cell Migration. Han, Bo,Lian, Ling,Li, Xin,Zhao, Chunfang,Qu, Lujiang,Yang, Ning,Liu, Changjun,Liu, Changjun. 2016

[2]Establishment of six homozygous MHC-B haplotype populations associated with susceptibility to Marek's disease in Chinese specific pathogen-free BWEL chickens. Gao, Caixia,Han, Lingxia,Liu, Jiasen,Jiang, Qian,Guo, Dongchun,Qu, Liandong,Han, Jianlin.

[3]Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration. Han, Bo,Lian, Ling,Li, Xin,Zhao, Chunfang,Qu, Lujiang,Yang, Ning,Liu, Changjun,Song, Jiuzhou.

[4]Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line. Lian, Ling,Li, Xin,Zhao, Chunfang,Han, Bo,Qu, Lujiang,Yang, Ning,Song, Jiuzhou,Liu, Changjun.

[5]Characterization of Copy Number Variation's Potential Role in Marek's Disease. Xu, Lingyang,He, Yanghua,Ding, Yi,Sun, Guirong,Carrillo, Jose Adrian,Li, Yaokun,Ghaly, Mona M.,Ma, Li,Song, Jiuzhou,Xu, Lingyang,Liu, George E.,Xu, Lingyang,Sun, Guirong,Li, Yaokun,Ghaly, Mona M.,Zhang, Huanmin. 2017

[6]Preparation and immunoprotection of subgroup B avian leukosis virus inactivated vaccine. Li, Xue,Dong, Xuan,Sun, Xiaolong,Li, Weihua,Zhao, Peng,Cui, Zhizhong,Li, Weihua,Wang, Xin. 2013

[7]Development of a one-step strip test for the diagnosis of chicken infectious bursal disease. Zhang, GP,Li, QM,Yan, YY,Guo, JQ,Li, XW,Deng, RG,Xiao, ZJ,Xing, GX,Yang, JF,Zhao, D,Cai, SJ,Zang, WM. 2005

[8]Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease. Ge, Jinying,Wang, Xijun,Tian, Meijie,Wen, Zhiyuan,Feng, Qiulin,Qi, Xiaole,Gao, Honglei,Wang, Xiaomei,Bu, Zhigao. 2014

[9]High level soluble expression and one-step purification of IBDV VP2 protein in Escherichia coli. Jiang, Dawei,Zhang, Gaiping,Yang, Guoyu,Song, Yapeng,Wang, Guoqiang,Wang, Jucai,Zhao, Baolei,Jiang, Dawei,Liu, Yunchao,Zhang, Gaiping,Ji, Pengchao,Liu, Chang,Song, Yapeng,Su, Yunfang,Wang, Guoqiang,Wang, Jucai,Zhao, Baolei,Deng, Ruiguang,Wang, Aiping,Chen, Yumei.

[10]gga-miR-2127 downregulates the translation of chicken p53 and attenuates chp53-mediated innate immune response against IBDV infection. Ouyang, Wei,Wang, Yong-shan,Meng, Kai,Pan, Qun-xing,Wang, Xiao-li,Xia, Xing-xia,Zhu, Yu-mei,Bi, Zhen-wei,Zhang, Hai-bin,Ouyang, Wei,Wang, Yong-shan,Meng, Kai,Pan, Qun-xing,Wang, Xiao-li,Xia, Xing-xia,Zhu, Yu-mei,Bi, Zhen-wei,Ouyang, Wei,Luo, Kai,Zhang, Hai-bin.

[11]Gene expression analysis of host spleen responses to Marek's disease virus infection at late tumor transformation phase. Lian, L.,Qu, L. J.,Sun, H. Y.,Chen, Y. M.,Yang, N.,Lamont, S. J.,Liu, C. J.. 2012

[12]Lipoprotein metabolism differs between Marek's disease susceptible and resistant chickens. Yuan, P.,Yu, Y.,Luo, J.,Tian, F.,Song, J.,Yu, Y.,Zhang, H.,Chang, S.,Ramachandran, R.,Zhang, L.. 2012

[13]Expression profiles of genes within a subregion of chicken major histocompatibility complex B in spleen after Marek's disease virus infection. Lian, L.,Qu, L. J.,Zheng, J. X.,Chen, Y. M.,Xu, G. Y.,Yang, N.,Liu, C. J.,Zhang, Y. P.. 2010

[14]Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis. Pan, Y,Cai, H,Li, SX,Tian, X,Li, T,Zhu, YX. 2003

[15]Expression of truncated Babesia microti apical membrane protein 1 and rhoptry neck protein 2 and evaluation of their protective efficacy. Wang, Guanbo,Efstratiou, Artemis,Moumouni, Paul Franck Adjou,Liu, Mingming,Jirapattharasate, Charoonluk,Guo, Huanping,Gao, Yang,Suzuki, Hiroshi,Igarashi, Ikuo,Xuan, Xuenan,Cao, Shinuo,Zhou, Mo.

[16]Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus. Li, Kai,Liu, Yongzhen,Liu, Changjun,Gao, Li,Zhang, Yanping,Gao, Yulong,Cui, Hongyu,Qi, Xiaole,Zhong, Li,Wang, Xiaomei.

[17]Protective Efficacy of the Inactivated H5N1 Influenza Vaccine Re-6 Against Different Clades of H5N1 Viruses Isolated in China and the Democratic People's Republic of Korea. Zeng, Xianying,Deng, Guohua,Liu, Liling,Li, Yanbing,Shi, Jianzhong,Chen, Pucheng,Feng, Huapeng,Tian, Guobin,Chen, Hualan,Zeng, Xianying,Deng, Guohua,Liu, Liling,Li, Yanbing,Shi, Jianzhong,Chen, Pucheng,Feng, Huapeng,Tian, Guobin,Chen, Hualan,Liu, Jingli,Guo, Xingfu,Mao, Shenggang,Yang, Fan,Chen, Zhiyu.

[18]Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Tong, Guang-Zhi.

[19]Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. Zheng, Haixue,Lian, Kaiqi,Yang, Fan,Jin, Ye,Zhu, Zixiang,Guo, Jianhong,Cao, Weijun,Liu, Huanan,He, Jijun,Zhang, Keshan,Li, Dan,Liu, Xiangtao.

[20]A safe and molecular-tagged Brucella canis ghosts confer protection against virulent challenge in mice. Qian, Jing,Bu, Zhaoyang,Lang, Xulong,Wang, Xinglong,Qian, Jing,Qian, Jing,Yan, Guangmou,Yang, Yanling,Wang, Xiuran.

作者其他论文 更多>>